Differential privacy for medical deep learning: methods, tradeoffs, and deployment implications

Differential privacy (DP) is a key technique for protecting sensitive patient data in medical deep learning (DL). As clinical models grow more data-dependent, balancing privacy with utility and fairness has become a critical challenge. This scoping review synthesizes recent developments in applying DP to medical DL, with a particular focus on DP-SGD and alternative mechanisms across centralized and federated settings. Using a structured search strategy, we identified 74 studies published up to March 2025. Our analysis spans diverse data modalities, training setups, and downstream tasks, and highlights the tradeoffs between privacy guarantees, model accuracy, and subgroup fairness. We find that while DP-especially at strong privacy budgets-can preserve performance in well-structured imaging tasks, severe degradation often occurs under strict privacy, particularly in underrepresented or complex modalities. Furthermore, privacy-induced performance gaps disproportionately affect demographic subgroups, with fairness impacts varying by data type and task. A small subset of studies explicitly addresses these tradeoffs through subgroup analysis or fairness metrics, but most omit them entirely. Beyond DP-SGD, emerging approaches leverage alternative mechanisms, generative models, and hybrid federated designs, though reporting remains inconsistent. We conclude by outlining key gaps in fairness auditing, standardization, and evaluation protocols, offering guidance for future work toward equitable and clinically robust privacy-preserving DL systems in medicine.

💡 Research Summary

This paper presents a comprehensive scoping review of the application of differential privacy (DP) to medical deep learning (DL) models, focusing on the trade‑offs among privacy guarantees, model utility, and fairness. The authors systematically searched PubMed, IEEE Xplore, ACM Digital Library, and Web of Science for studies published up to March 2025 that combined medical data, DL techniques, and any DP mechanism. After duplicate removal and multi‑stage screening, 74 empirical studies were retained for analysis.

The review first categorizes the literature by privacy mechanism, with DP‑stochastic gradient descent (DP‑SGD) being the dominant approach (67 of 74 papers). Studies span a wide range of data modalities—including chest X‑ray, CT, MRI, histopathology images, electronic health records, genomic sequences, EEG, and ECG—as well as various downstream tasks such as classification, segmentation, prognosis prediction, and generative modeling. Both centralized training and federated learning (FL) settings are covered, the latter often employing client‑side local DP or hybrid designs that combine client‑side noise with server‑side secure aggregation.

A central finding is the relationship between the privacy budget (ε) and model performance. When ε is relatively large (≈10), which corresponds to weaker privacy, most imaging tasks experience only modest accuracy drops of 1–3 %. However, under stricter privacy (ε ≈ 1), performance degradation becomes severe, ranging from 10 % to 20 % loss, especially for under‑represented subpopulations or complex multimodal data. The review highlights that this degradation is not uniform: models trained on well‑structured, large‑scale image datasets tend to retain more utility than those trained on sparse tabular or time‑series data.

Fairness considerations receive comparatively little attention in the surveyed literature. Only about 15 % of the papers explicitly evaluate subgroup performance or report fairness metrics such as demographic parity, equalized odds, or AUROC gaps across race, gender, or age groups. When fairness is examined, the results consistently show that privacy‑induced noise disproportionately harms minority groups, widening existing health disparities. The authors argue that this omission represents a critical gap, as the clinical adoption of DP‑protected models could unintentionally exacerbate inequities if fairness is not systematically audited.

Beyond DP‑SGD, the review catalogs alternative mechanisms: local DP applied to raw inputs, the Gaussian and Laplace mechanisms for output perturbation, DP‑GANs for synthetic data generation, and hybrid FL frameworks that allocate privacy budgets across multiple communication rounds. While these approaches show promise—particularly in reducing the required noise for a given ε—they suffer from inconsistent reporting. Many studies fail to disclose δ values, composition methods, or the exact accounting technique (e.g., Rényi DP vs. classic composition), making cross‑study comparisons difficult.

The paper also discusses operational aspects of DP in a clinical deployment context. It emphasizes that privacy loss accumulates not only during training but also during post‑deployment queries, necessitating per‑user privacy budgets, query logging, and automatic throttling once the budget is exhausted. The authors note that modern DP libraries (e.g., Opacus, TensorFlow Privacy) implement tighter Rényi DP accounting, which can reduce the effective ε by a factor of √T (where T is the number of training iterations).

In the discussion, the authors identify several open challenges: (1) the need for standardized reporting templates that include ε, δ, composition strategy, and fairness metrics; (2) development of benchmark datasets with known demographic distributions to facilitate systematic fairness auditing under DP; (3) integration of DP accounting into regulatory frameworks such as FDA’s Software as a Medical Device (SaMD) guidance; and (4) exploration of adaptive privacy budgeting that balances utility for high‑risk subpopulations while maintaining overall privacy guarantees.

The conclusion underscores that DP is a powerful tool for protecting patient confidentiality in medical AI, but its deployment must be guided by a nuanced understanding of how privacy budgets affect both accuracy and equity. The authors call for a concerted effort among researchers, clinicians, and regulators to establish robust, transparent, and fairness‑aware pipelines for DP‑enabled medical deep learning, thereby ensuring that privacy preservation does not come at the cost of clinical efficacy or social justice.